Autopsy report · NCT03438500

Cardiac Shock Wave Treatment in Patients With Reduced Coronary Flow Reserve

“Sponsor \& PI decision”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Storz Medical AG

Sponsor type

Industry

Conditions

Refractory Angina Pectoris; Ischemic Heart Disease; Coronary Artery Disease

Interventions

Cardiac Extracorporeal Shockwave Therapy (Modulith SLC)

Participants

0

Sites

1

Countries

Germany

Trials that died the same way

• Value of 3D Modeling in Spine Surgery
  “Sponsor and PI decision” (97% match in meaning)
• Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)
  “Sponsor Decision” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.